deltatrials
Recruiting PHASE3 INTERVENTIONAL 1-arm NCT02638389

Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care

Phase III Multicentric Study Evaluating the Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Interventions Sirolimus
Updated 9 times since 2017 Last updated: Feb 23, 2023 Started: Jan 25, 2016 Primary completion: Apr 1, 2025 Completion: Apr 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Vascular Malformations and is currently actively recruiting participants. Cliniques universitaires Saint-Luc- Université Catholique de Louvain leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotRecruiting~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2023 · 26 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 11 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  4. Mar 2023 — Jul 2024 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Mar 2023 [monthly]

    Recruiting PHASE3

Show 4 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Recruiting PHASE3

  2. Jul 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  3. Feb 2017 — Jul 2017 [monthly]

    Recruiting PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Data source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .